Patents Represented by Attorney M. Alexander
  • Patent number: 6939865
    Abstract: A subject-matter of the invention is a pharmaceutical composition for parenteral administration, characterized in that it comprises: dronedarone or one of its pharmaceutically acceptable salts as active principle; a physiologically acceptable buffer solution capable of maintaining the pH of the composition between 3 and 5; a physiologically acceptable water-soluble ?-cyclodextrin derivative.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: September 6, 2005
    Assignee: Sanofi-Aventis
    Inventors: Frédérique Bourriague-Seve, Thierry Breul